Treatment with androgen receptor inhibitors is associated with an increased risk for falls and fractures in men with prostate cancer, show findings from a meta-analysis.
The risk for clinically significant bleeding during concurrent treatment with VEGFR–tyrosine kinase inhibitors and factor Xa inhibitors is doubled when compared with factor Xa inhibitors alone, research shows.
Real-world lung cancer screening rates are generally much lower than those reported in randomized controlled trials, particularly when shorter screening intervals are used, US study findings indicate.
Adding alpelisib to fulvestrant improves overall survival in people with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer, but not significantly so, show data from the phase 3 SOLAR-1 trial.
The number of people initiating systemic cancer therapies fell substantially at the start of the COVID-19 pandemic but then recovered rapidly with the implementation of new treatment guidance, UK study data show.
Treatment with androgen receptor inhibitors is associated with an increased risk for falls and fractures in men with prostate cancer, show findings from a meta-analysis.
Vitamin D supplementation is associated with a reduced risk for metastatic or fatal cancer, but the benefit appears to be largely restricted to people with normal BMI, shows an analysis of VITAL study data.
The addition of indoximod to taxane chemotherapy does not improve the outcomes of patients with HER2-negative metastatic breast cancer, research suggests.
Meet the Editorial Board
Our international Editorial Board members Dr Fiona Blackhall (Christie Hospital, Manchester, UK) and Dr Axel Merseburger (University Hospital Schleswig-Holstein, Germany) work closely with the editorial team to highlight gaps in coverage and select topics to feature on this digital platform.
Why register? Medicine Matters oncology is a free resource providing the latest news and clinical guidance
Register today and receive updates directly to your inbox! Medicine Matters oncology has been specifically developed for the time-limited healthcare professional who is looking for a single resource providing credible information on current practice and the latest advances in oncology. Already registered? Log in now to unlock your access.
